Back to Journals » Vascular Health and Risk Management » Volume 3 » Factor eight inhibitor bypass activity (FEIBA) in the management of bleeds in hemophilia patients with high-titer inhibitors
Please verify you are not a robot.
Back to Journals » Vascular Health and Risk Management » Volume 3 » Factor eight inhibitor bypass activity (FEIBA) in the management of bleeds in hemophilia patients with high-titer inhibitors
Please verify you are not a robot.